AI assistant
Sending…
THERACRYF PLC — Major Shareholding Notification 2020
Jul 17, 2020
7964_mrq_2020-07-17_23d9489f-9e07-47d0-9147-24f172a8dcc6.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 3768T
Evgen Pharma PLC
17 July 2020
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Evgen Pharma plc | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | √ | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | change in percentage of voting rights arising upon a new issue of shares by the issuer | ||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Enterprise Ventures Limited | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv |
RisingStars Growth Fund II LP | ||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
15th July 2020 | ||||
| 6. Date on which issuer notified: | 17th July 2020 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
3%/2%/1% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights | ||||||||||||
| Direct | Direct xi | Indirecti | Direct | Indirect | ||||||||||||
| GB00BSVYN304 | 4,419,268 | 4,419,268 | Nil | Nil | Nil | Nil | Nil | |||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
| None | ||||||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| None | Nominal | Delta | ||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| Nil | Nil | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: |
||
| 12. Date on which proxy holder will cease to hold voting rights: |
||
| 13. Additional information: | ||
| 14. Contact name: | Enterprise Ventures Limited | |
| 15. Contact telephone number: | 01772 270 570 | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
HOLKZGMNGNRGGZM
More from THERACRYF PLC
Major Shareholding Notification
2026
May 26
Major Shareholding Notification
2026
May 15
Major Shareholding Notification
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 20
M&A Activity
2026
Apr 14
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 26
Regulatory Filings
2026
Jan 5